866-997-4948(US-Canada Toll Free)

Investigation Report on China Ossotide Market, 2010-2019

Published By :

China Research and Intelligence Co., Ltd. (CRI)

Published Date : Jun 2015

Category :

Manufacturing, Packaging & Detailing

No. of Pages : 35 Pages

According to statistics, the incidence of rheumatoid arthritis (RA) is 0.2%-0.36% and the number of cases is 5-10 million in China. Apart from RA, osteoarthritis, an expression of degraded joint function, is also common to see. With the ageing population in China, over 60% of elder people aged above 60 suffer from osteoarthritis, says a study. Patients with osteoarthritis typically show reduced mobility and life quality caused by joint pain, malformation and joint dysfunction.

Ossotide can not only regulate bone metabolism, stimulate osteoblast proliferation, accelerate new bone formation but also regulate calcium-phosphorus metabolism, increase calcium deposits so as to prevent osteoporosis. Ossotide injection and compound ossotide injection was first developed by Nanjing Xinbai Pharmaceutical Co., Ltd which was formerly Nanjing Biochemical Pharmaceutical Factory. In recent years, compound ossotide injection market has shown increasingly fierce competition as it is going from short supply to oversupply, from huge profits to meager profit. Besides, the rise in raw material price has stressed the profit margins.

After entering China market, ossotide is generally growing despite a decline in 2013 with annual sales value rising from less than CNY 60 million in 2005 to CNY 464 million in 2014 and CAGR during this period reaching over 26%. According to CRI’s market survey, ossotide in the Chinese market mainly come from Harbin Medisan Pharmaceutical Co., Ltd, ZBD Pharmaceutical, Heilongjiang Jiangshi Pharmaceutical Co., Ltd, among which Harbin Medisan Pharmaceutical Co., Ltd has the largest market share of about 19% for sales value in 2014.

The market size of ossotide is expected to keep growing in the next few years in China.

Readers can get at least the following information from this report:
  • market size of ossotide in China
  • competitive landscape of ossotide in Chinese market
  • price of ossotide made by different enterprises in China
  • market outlook of ossotide in China
The author suggests the following groups of people purchase this report:
  • manufacturers of drugs for bones and muscles
  • investors/ research institutions interested in Chinese medicine market
  • any interest in the Chinese medicine market, please contact CRI for customized survey service
Table of Content

1 Related Concepts of Ossotide
1.1 Indication
1.2 Sales Status in Global Market

2 Market Profile of Ossotide in China
2.1 Patent and Approval Status of Ossotide in China
2.2 Major Manufacturers
2.3 Market Size

3 Survey on Sales Status of Ossotide in China, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions

4 Survey on Market Share of Major Manufacturers of Ossotide in China, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume

5 Survey on Dosage Forms of Ossotide in China, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2Share of Different Dosage Forms by Sales Volume

6 Reference Price of Ossotide in Chinese Hospitals in 2014
6.1 Harbin Sanctity Pharmaceutical Co., Ltd (Trade Name: Gu Yue)
6.2 Kaifeng Canon Pharmaceutical Co., Ltd
6.3 Nanjing Xinbai Pharmaceutical Co., Ltd (Trade Name: Gu Qiang)
6.4 Harbin Medisan Pharmaceutical Co., Ltd (Trade Name: Mai Jin Li)
6.5 Harbin Songhe Pharmaceutical Co., Ltd (Trade Name: Song He)
6.6 Heilongjiang Jiangshi Pharmaceutical Co., Ltd (Trade Name: Gu Jie)
6.7 ZBD Pharmaceutical

7 Major Manufacturers of Ossotide in Chinese Market, 2010-2014
7.1 Harbin Sanctity Pharmaceutical Co., Ltd
7.2 Harbin Medisan Pharmaceutical Co., Ltd
7.3 Heilongjiang Jiangshi Pharmaceutical Co., Ltd
7.4 Harbin Songhe Pharmaceutical Co., Ltd
7.5 Kaifeng Canon Pharmaceutical Co., Ltd

8 Market Outlook of Ossotide in China, 2015-2019
8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape

List of Chart


Chart Approval Information of Ossotide in China
Chart Sales Status of Ossotide in China
Chart Sales Value of Ossotide in China, 2010-2014
Chart Sales Value of Ossotide in Some Regions in China, 2010-2014
Chart Sales Volume of Ossotide in China, 2010-2014
Chart Market Share of TOP5 Manufacturers of Ossotide for Sales Value in China, 2010-2014
Chart Sales Value and Market Share of Ossotide Made by Harbin Medisan in China, 2010-2014
Chart Sales Value and Market Share of Ossotide Made by Harbin Sanctity in China, 2010-2014
Chart Sales Value and Market Share of Ossotide Made by Harbin Songhe in China, 2010-2014
Chart Sales Value and Market Share of Ossotide Made by ZBD in China, 2010-2014
Chart Sales Value and Market Share of Ossotide Made by Heilongjiang Jiangshi in China, 2010-2014
Chart Sales Value and Market Share of Ossotide Injection in China, 2010-2014
Chart Sales Value and Market Share of Ossotide Tablet in China, 2010-2014
Chart Sales Volume and Market Share of Ossotide Injection, 2010-2014
Chart Price of Ossotide Made by Harbin Sanctity Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Ossotide Made by Kaifeng Canon Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Ossotide Made by Nanjing Xinbai Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Ossotide Made by Harbin Medisan Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Ossotide Made by Harbin Songhe Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Ossotide Made by Heilongjiang Jiangshi Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Ossotide Made by ZBD Pharmaceutical in Some Chinese Cities in 2014

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *